{"id":"kanglaite","rwe":[],"tags":[],"trials":[],"_chembl":null,"aliases":["Kanglaite injection","Coicis Oil injection","KLTi"],"patents":[],"pricing":[],"offLabel":[],"timeline":[],"_dailymed":null,"ecosystem":[],"_scrapedAt":"2026-03-27T23:50:50.794Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"references":[],"biosimilars":[],"competitors":[],"labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT03101514","phase":"PHASE2","title":"Kanglaite Reduce the Toxicity of Radiotherapy of Head and Neck Cancer Phase II Study","status":"COMPLETED","sponsor":"First Affiliated Hospital of Harbin Medical University","startDate":"2017-01-01","conditions":"Head and Neck Cancer, Radiotherapy","enrollment":53},{"nctId":"NCT03986528","phase":"PHASE4","title":"Clinical Trial of Kanglaite Injection (KLTi) in Advanced Non-Small Cell Lung Cancer (NSCLC)","status":"UNKNOWN","sponsor":"Jie Li","startDate":"2019-08-28","conditions":"NSCLC","enrollment":334},{"nctId":"NCT03631459","phase":"","title":"A Multicenter Real World Study of Kanglaite for Cancer Cachexia","status":"UNKNOWN","sponsor":"Zhejiang Kanglaite Pharmaceutical Co.Ltd","startDate":"2018-08-20","conditions":"Cancer Cachexia","enrollment":100000},{"nctId":"NCT02553187","phase":"PHASE4","title":"A Prospective, Randomized, Controlled, Multicenter Study of Kanglaite Injection for the Treatment of Cancer Cachexia","status":"UNKNOWN","sponsor":"Zhejiang Kanglaite Pharmaceutical Co.Ltd","startDate":"2015-09","conditions":"Cancer Cachexia","enrollment":160},{"nctId":"NCT00733850","phase":"PHASE2","title":"Safety and Exploratory Efficacy of Kanglaite Injection in Pancreatic Cancer","status":"COMPLETED","sponsor":"KangLaiTe USA","startDate":"2008-08","conditions":"Pancreatic Cancer","enrollment":85},{"nctId":"NCT01483586","phase":"PHASE2","title":"Safety and Efficacy of Kanglaite Gelcaps in Prostate Cancer","status":"TERMINATED","sponsor":"KangLaiTe USA","startDate":"2011-11","conditions":"Prostate Cancer","enrollment":90},{"nctId":"NCT01640730","phase":"PHASE2","title":"Safety and Exploratory Efficacy of Kanglaite Injection in Non Small Cell Lung Cancer","status":"TERMINATED","sponsor":"KangLaiTe USA","startDate":"2012-05","conditions":"Stage IV NSCLC","enrollment":1},{"nctId":"NCT00031031","phase":"PHASE1","title":"Kanglaite Injection Phase I Study","status":"COMPLETED","sponsor":"KangLaiTe USA","startDate":"2001-06","conditions":"Solid Tumors Refractory To Standard Therapy, Neoplasms","enrollment":16}],"_emaApprovals":[],"_faersSignals":[{"count":1,"reaction":"ACUTE CORONARY SYNDROME"},{"count":1,"reaction":"DEATH"},{"count":1,"reaction":"DRUG-INDUCED LIVER INJURY"},{"count":1,"reaction":"DYSURIA"},{"count":1,"reaction":"HEPATIC FUNCTION ABNORMAL"},{"count":1,"reaction":"LARYNGEAL OEDEMA"},{"count":1,"reaction":"LIVER FUNCTION TEST ABNORMAL"},{"count":1,"reaction":"MYELOSUPPRESSION"},{"count":1,"reaction":"NAUSEA"},{"count":1,"reaction":"PLATELET COUNT DECREASED"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"formularyStatus":[],"_approvalHistory":[],"developmentCodes":[],"ownershipHistory":[],"publicationCount":95,"therapeuticAreas":["Other"],"biosimilarFilings":[],"companionDiagnostics":[],"genericManufacturerList":[],"phase":"marketed","status":"active","brandName":"Kanglaite","genericName":"Kanglaite","companyName":"First Affiliated Hospital of Harbin Medical University","companyId":"first-affiliated-hospital-of-harbin-medical-university","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":1,"regulatoryByCountry":[{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":1,"withResults":1},"verificationStatus":"enriching","dataCompleteness":{"mechanism":false,"indications":false,"safety":false,"trials":true,"score":1}}